Ditchcarbon
  • Contact
  1. Organizations
  2. Bio-Thera Solutions, Ltd.
Public Profile
Pharmaceutical Preparation Manufacturing
CN
updated 13 days ago

Bio-Thera Solutions, Ltd. Sustainability Profile

Company website

Bio-Thera Solutions, Ltd., headquartered in China, is a prominent biopharmaceutical company specialising in the development of innovative therapies for autoimmune diseases and oncology. Founded in 2010, the company has made significant strides in the industry, focusing on monoclonal antibodies and biosimilars that address unmet medical needs. With a strong presence in both domestic and international markets, Bio-Thera has established itself as a leader in the biopharmaceutical sector. Its core products, including the well-regarded BAT1806, exemplify the company's commitment to quality and efficacy, setting them apart from competitors. Recognised for its robust pipeline and strategic partnerships, Bio-Thera Solutions continues to enhance its market position, contributing to advancements in healthcare and improving patient outcomes globally.

DitchCarbon Score

How does Bio-Thera Solutions, Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

22

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Bio-Thera Solutions, Ltd.'s score of 22 is lower than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.

25%

Let us know if this data was useful to you

Bio-Thera Solutions, Ltd.'s reported carbon emissions

Bio-Thera Solutions, Ltd., headquartered in China, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company has not established any documented reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. As there is no available data on their emissions or reduction initiatives, it is unclear how Bio-Thera Solutions, Ltd. is addressing climate change within its operations. The lack of reported emissions and targets suggests that the company may still be in the early stages of developing a comprehensive climate strategy. In the broader context of the biopharmaceutical industry, many companies are increasingly focusing on sustainability and carbon reduction, often setting ambitious targets to align with global climate goals. However, without specific commitments or data from Bio-Thera Solutions, it is difficult to assess their position in this evolving landscape.

How Carbon Intensive is Bio-Thera Solutions, Ltd.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Bio-Thera Solutions, Ltd.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Bio-Thera Solutions, Ltd.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Bio-Thera Solutions, Ltd. is in CN, which we do not have grid emissions data for.

Bio-Thera Solutions, Ltd.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Bio-Thera Solutions, Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Bio-Thera Solutions, Ltd.'s Emissions with Industry Peers

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Eli Lilly and Company

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 19 hours ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Jiangsu Chia Tai-Tianqing Pharmaceutical Co. Ltd

CN
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

TESSA

FI
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated about 2 hours ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy